Changzhou Siyao Pharmaceuticals CO.,LTD Company Profile

11:59 EDT 25th June 2018 | BioPortfolio

Changzhou Siyao Pharmaceutical Co.,Ltd. is a comprehensive pharmaceutical company providing full-service of research and development, manufacture, sales and distribution. With over 400 staffs, in 2005, the company's sales amount is 0.5 billion RMB, and the tax paid to the government is 50 million RMB.
Changzhou Siyao is a national-grade high-tech enterprise with a post doctorate state. Presently, the Company has obtained GMP-certificate as well as ISO-14001. 3 Products have passed FDA inspection and got CEP certificate. In 2005, Changzhou Siyao is named as "Four-Star Enterprise" and "one of the ten outstanding companies for technology innovation" by Changzhou Municipal government.

The company, equipped with a first-class R&D Centre and a quality testing centre, is undertaking 5 projects from National Scientific and Technologic Projects and National 863 Projects and has got 21 patents. The company has been awarded for many times by the competent authorities because of high quality. Aoke? series have been named as "Jiangsu Brand Product" for 8 years successively.


Phone: 86-519-8811176
Fax: 0086-519-8825678

News Articles [517 Associated News Articles listed on BioPortfolio]

From its base at Changzhou National Hi-Tech District, LANXESS continues to benefit from China's ...

Located at No. 8, Huanghai Road, Changzhou Xinbei District in CND, LANXESS Changzhou Siteis responsible for the production of leather chemicals, synthetic rubber and Read more...

STA Pharmaceutical’s Changzhou facility passes first FDA inspection

STA Pharmaceutical (WuXi STA), a subsidiary of WuXi AppTec has announced that its active pharmaceutical ingredient (API) R&D and manufacturing facility in Changzhou, China, has passed its first in...

Oxford Vacmedix Raises $12.5 Million for Therapeutic Vaccines from Asian Investors

Oxford Vacmedix, a UK-Changzhou biopharma, closed a $12.5 million Series A funding from South Korean and China investors to develop therapeutic cancer vaccines. OVM's two lead vaccines target cervical...

Critical Contrast: Ironwood Pharmaceuticals

Ironwood Pharmaceuticals and Infinity Pharmaceuticals are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, d...

20152023 World 4,4'Difluorobenzophenone Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 15022018] Prices from USD $2800

SummaryxxxThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and...

WuXi STA gets FDA nod for new facility

Chinese pharma development firm WuXi STA has announced that its newly-built facility in Changzhou has…

WuXi STA’s API site receives FDA nod following first inspection

WuXi STA has passed its first FDA inspection at its active pharmaceutical ingredient (API) development and manufacturing facility located in Changzhou, China.

GW Pharmaceuticals ADR: Kommt es jetzt zum Ausbruch? Trading-Chance!

Es gibt ein weiteres Unternehmen GW Pharmaceuticals, das vorwiegend Cannabis herstellt und somit als "Pflanzenzüchter" zu werten ist. GW Pharmaceuticals ADR ist ein Biotech-Unternehmen, das sich zw.....

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]


Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]


PubMed Articles [136 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Short-term effects of ambient air pollutants and myocardial infarction in Changzhou, China.

Ambient air pollution had been shown strongly associated with cardiovascular diseases. However, the association between air pollution and myocardial infarction (MI) is inconsistent. In the present stu...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Impact of Pharmaceuticals on the Environment: Risk Assessment Using QSAR Modeling Approach.

An extensive use of pharmaceuticals and the widespread practices of their erroneous disposal measures have made these products contaminants of emerging concern (CEC). Especially, active pharmaceutical...

Clinical Trials [216 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1326 Associated Companies listed on BioPortfolio]

Changzhou Siyao Pharmaceuticals CO.,LTD

Changzhou Siyao Pharmaceutical Co.,Ltd. is a comprehensive pharmaceutical company providing full-service of research and development, manufacture, sales and distribution. With over 400 staffs, in 2005...

Jiaerke Pharmaceuticals Group Corp.,Ltd

Changzhou Jiaerke Pharmaceuticals Group Corp.,Ltd. Is a professional pharmaceuticals company, which has more than 20 years of experiences in producing steroid hormone products and other organic chemic...

Changzhou Niutang Chemical Plant Co.,Ltd

Changzhou Niutang Chemical Plant Co.,Ltd located at the southern part of Changzhou city.The distance to Shanghai Pudong Airport is only 2 hours by car.Since the establishment in 1969,Niutang Chemical ...

Chart Cryogenic Engineering Systems (Changzhou) Co,.Ltd.

Chart Industries, Inc. is a leading global supplier of standard and custom-engineered products and systems serving a wide variety of low-temperature and cryogenic applications. Headquartered in Clevel...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

More Information about "Changzhou Siyao Pharmaceuticals CO.,LTD" on BioPortfolio

We have published hundreds of Changzhou Siyao Pharmaceuticals CO.,LTD news stories on BioPortfolio along with dozens of Changzhou Siyao Pharmaceuticals CO.,LTD Clinical Trials and PubMed Articles about Changzhou Siyao Pharmaceuticals CO.,LTD for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Changzhou Siyao Pharmaceuticals CO.,LTD Companies in our database. You can also find out about relevant Changzhou Siyao Pharmaceuticals CO.,LTD Drugs and Medications on this site too.

Quick Search


Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record